BDBM600033 5-{4-amino-5-[(3,3-difluoroazetidin-1- yl)methyl]pyrrolo[2,1-f][1,2,4]triazin-7-yl}-N- [(3R,4S)-4-fluoro-1-(2-fluoro-2- methylpropanoyl)pyrrolidin-3-yl]-2-(methoxy- d3)nicotinamide::US11618753, Example 1271

SMILES COc1ncc(cc1C(=O)N[C@@H]1CN(C[C@@H]1F)C(=O)C(C)(C)F)-c1cc(CN2CC(F)(F)C2)c2c(N)ncnn12

InChI Key InChIKey=YWTZOOYXJBEGNR-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 600033   

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM600033(US11618753, Example 1271 | 5-{4-amino-5-[(3,3-difl...)
Affinity DataIC50: 1.90E+3nMAssay Description:A solution was prepared containing 0.2 nM Anti GST-Tb (Cisbio, 61GSTTLB), 90.6 nM probe and 1 nM His-GST-TVMV-hRIPK1(1-324) in FRET Buffer (20 mM HEP...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2023
Entry Details
Go to US Patent